MoonLake Immunotherapeutics (MLTX) Debt to Equity (2021)
MoonLake Immunotherapeutics' Debt to Equity history spans 1 years, with the latest figure at -$1.29 for Q4 2021.
- Quarterly Debt to Equity changed N/A to -$1.29 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was -$1.29 through Dec 2021, changed N/A year-over-year, with the annual reading at -$1.29 for FY2021, N/A changed from the prior year.
- Debt to Equity came in at -$1.29 for Q4 2021.
- In the past five years, Debt to Equity ranged from a high of -$1.29 in Q4 2021 to a low of -$1.29 in Q4 2021.